Table 1 Clinical and laboratory findings of the 125 patients with PE
From: A scoring model for diagnosis of tuberculous pleural effusion
Total (n = 125) | TBPE (n = 63) | Non-TBPE (n = 62) | p value | |
|---|---|---|---|---|
Age (years) | 58.0 (38.0–70.5) | 42.0 (29.0–65.0) | 67.0 (53.0–74.0) | 0.000 |
Male | 71 (56.8%) | 46 (73.0%) | 25 (40.3%) | 0.000 |
Cancer | 44 (35.2%) | 1 (1.6%) | 43 (69.4%) | 0.000 |
Unilateral PE | 116 (92.8%) | 62 (98.4%) | 54 (87.1%) | 0.017 |
Cough | 101 (80.8%) | 52 (82.5%) | 49 (79.0%) | 0.656 |
Fever | 41 (32.8%) | 33 (52.4%) | 8 (12.9%) | 0.000 |
Chest pain | 50 (40.0%) | 30 (47.6%) | 20 (32.3%) | 0.080 |
Night sweats | 4 (3.2%) | 3 (4.8%) | 1 (1.6%) | 0.619 |
In blood | ||||
ESR | 35.0 (21.5–56.0) | 40.0 (28.0–60.0) | 30.0 (12.0–45.7) | 0.031 |
CRP | 36.1 (13.2–90.8) | 76.5 (30.1–131.3) | 18.1 (8.4–41.0) | 0.000 |
T-SPOT | 73 (58.4%) | 59 (93.7%) | 14 (22.6%) | 0.000 |
In PE | ||||
L% | 90 (77.5–96.0) | 93.0 (84.0–98.0) | 85.0 (67.7–94.0) | 0.000 |
Protein | 64.7 (53.0–79.6) | 69.5 (58.5–81.6) | 61.7 (50.4–77.5) | 0.063 |
ADA | 26.7 (8.6–41.7) | 40.9 (33.6–49.3) | 9.5 (7.1–12.9) | 0.000 |
LDH | 306.2 (216.2–571.4) | 415.1 (262.0–610.7) | 269.4 (207.7–392.9) | 0.299 |